NeuroPace
Latest round
- Series B
Last raised
- Aug 2020
Total raised
- $123M
Investors
- 12
About NeuroPace
Based in the US, NeuroPace, Inc.NeuroPace, Inc. was founded in 1999 and is headquartered in Mountain View, California, US.NeuroPace focuses on providing advanced medical solutions for drug-resistant epilepsy with its RNS® System. This system delivers personalized, real-time treatment directly at the source of seizures, tailored to patients' unique patterns, specifically for adults with up to two identified epileptogenic foci.67 mn. The company is focusing on developing additional features for the RNS® System and plans to target new geographic markets, particularly in Europe and Asia, by 2025.
Who invested in NeuroPace
12 investors across 3 rounds
See all investors in NeuroPace
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about NeuroPace
Who invested in NeuroPace?
NeuroPace has 12 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NeuroPace raised?
NeuroPace has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did NeuroPace last raise money?
NeuroPace's most recent round on record is a Series B, in Aug 2020.
What does NeuroPace do?
Based in the US, NeuroPace, Inc.
Where is NeuroPace headquartered?
NeuroPace is headquartered in Mountain View, US.
Which VCs invest in companies like NeuroPace?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at NeuroPace's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like NeuroPace? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.